Abstract
Fluorescent turn-on probes for nitric oxide based on seminaphthofluorescein scaffolds were prepared and spectroscopically characterized. The Cu(II) complexes of these fluorescent probes react with NO under anaerobic conditions to yield a 20- to 45-fold increase in integrated emission. The seminaphthofluorescein-based probes emit at longer wavelengths than the parent FL1 and FL2 fluorescein-based generations of NO probes, maintaining emission maxima between 550 and 625 nm. The emission profiles depend on the excitation wavelength; maximum fluorescence turn-on is achieved at excitations between 535–575 nm. The probes are highly selective for NO over other biologically relevant reactive nitrogen and oxygen species including NO3 −, NO2 −, HNO, ONOO−, NO2, OCl−, and H2O2. The seminaphthofluorescein-based probes can be used to visualize endogenously produced NO in live cells as demonstrated using Raw 264.7 macrophages.
Introduction
The multifaceted roles of biological nitric oxide (NO) have continued to emerge since the initial discovery that NO is the endothelium-derived relaxing factor (EDRF).1–3 Subsequent studies revealed that nitric oxide is an important signaling molecule in the immune, cardiovascular, and nervous systems.4–6 The delicate balance of NO production, action, and translocation requires tightly regulated homeostasis because a breakdown in NO homeostasis is associated with a variety of pathological conditions ranging from carcinogenesis to neurodegradation.7–13 In order to advance our understanding of pivotal roles played by NO in plants, bacteria, invertebrates, and mammals, chemists have devised strategies to detect this important biological messenger.6,14–19 Although several strategies are currently employed to detect NO either directly or indirectly, the use of fluorescent probes offers distinct advantages, including high sensitivity and convenience when applied using common microscopic techniques, to yield valuable spatiotemporal information on biologically generated NO.
Fluorescent probes based on small molecule fluorophores, single-walled carbon nanotubes (SWNTs), and proteins have been reported.20–31 Small molecule fluorescent probes typically rely on one of two strategies for NO detection. The first strategy utilizes organic moieties with electron-rich components, such as 1,2-diaminobenzenes, that react with an oxidation product of NO, such as N2O3, to form an electron deficient product, such as a triazole, to modulate the emission of the fluorophore.22,32–35 Although such probes comprise the majority of small molecule fluorescent sensors for NO, their inability to react with NO directly, relying on an indirect response that requires a sufficiently oxygenated environment to function, is a liability. The second main strategy used in the preparation of small molecule-based NO probes is to employ transition metals to modulate the fluorescence of a pendant fluorophore. In contrast to purely organic NO probes, metal-based probes detect NO directly. The close proximity of a transition metal can either quench the fluorescence of a pendant fluorophore until it reacts with NO, or it can facilitate reaction of NO with a dye component. Metal-based fluorescent probes include those based on Co(II), Fe(II), Ru(II), Cu(II), or Rh(II).32,36–41
Previously, we reported FL1 and FL2 fluorescent probe families for imaging endogenous nitric oxide in live cells and tissue; these sensors employ Cu(II) to modulate NO reactivity.25,36,42–45 The probes bind Cu(II) at an 8-aminoquinaldine unit appended to the fluorophore. Upon treatment with NO under anaerobic conditions, the Cu(II) ion is reduced to Cu(I) with concomitant nitrosation of the secondary nitrogen to form the fluorescent nitrosamine product (Figure 1).43,46 Probes from the CuFL1 and CuFL2 families can detect endogenous NO in cell culture and live tissue slices, emitting in the region of the spectrum typical for fluorescein-based dyes, with maxima near 525 nm. To improve the utility of these NO probes, scaffolds that emit at longer wavelengths are desirable. Such probes would not only expand the palette of colors available for multi-dye imaging experiments, but also require lower energy excitation and thus diminish tissue damage. Furthermore, longer wavelength probes facilitate deeper imaging in live tissue slices or live animals. To address these goals, the FL1 scaffold was modified to emit at longer wavelengths by extending the fluorescein system to a seminaphthofluorescein moiety. Here, we report the synthesis, photophysical characterization, and cellular imaging experiments of a family of seminaphthofluorescein-based SNFL probes that are selective for nitric oxide.
Figure 1.
Schematic showing the mechanism of fluorescence response for Cu(II)-based NO probes such as FL1 and FL2.
Results and Discussion
To extend the emission wavelengths of the FL1 family of NO probes, we adopted similar synthetic methodologies to extend the π-system by incorporation of a seminaphthofluorescein moiety. Seminaphthofluorescein dyes have been used as fluorescent probes for numerous biological applications including metal ion detection and pH measurements.47–53 Such dyes typically emit between 550 and 625 nm, values compatible with common yellow, orange, or red filter sets in fluorescence microscopes.
Synthesis
The first step in the synthesis of the seminaphthofluorescein NO probes involved bromination of the benzoate derivative 1 to form the desired bromomethyl species 3 (Scheme 1).53 During this reaction, we noticed that an excess of brominating agent 2 and at extended times resulted in over-bromination to yield 4. The position of the bromine atom was confirmed by 2D NMR spectroscopy and single crystal X-ray crystallography (Figures S1-S3, Table S1). Kornblum oxidation of the bromomethyl derivative 3 and 4 yielded the respective aldehydes 5 and 6, which were coupled to substituted 8-aminoquinaldines (7, 8) by reductive amination to yield the final constructs SNFL1, SNFL1E, SNFL1Br, and SNFL1EBr.
Scheme 1.
Preparation of the seminaphthofluorescein family of probes for nitric oxide. See experimental section for conditions.
Photophysical Properties
The seminaphthofluorescein probes show two overlapping bands in the UV-vis spectrum at ~495/520 nm for SNFL1 (ε496 = 8500 ± 100 M−1 cm−1, ε517 = 8700 ± 100 M−1 cm−1) and SNFL1E (ε496 = 5030 ± 40 M−1 cm−1, ε519 = 5200 ± 50 M−1 cm−1) and at ~505/530 nm for the brominated analogs SNFL1Br (ε505 = 4450 ± 50 M−1 cm−1, ε530 = 4650 ± 40 M−1 cm−1) and SNFL1EBr (ε501 = 4070 ± 40 M−1 cm−1, ε532 = 3930 ± 30 M−1 cm−1). The Cu(II) complexes display slight bathochromic shifts in absorbance maxima but otherwise have photophysical properties similar to those of the free ligands (Table 1). Excitation at either of the absorbance maxima results in weak emission in the range 535–545 nm, corresponding to the off-states of the probes.
Table 1.
Photophysical Properties of Seminaphthofluorescein NO Probes and Representative Properties of FL1 and FL2 Probes for Comparison.a
Absorption λmax (nm), ε × (104 M−1 cm−1) | Emission λmax (nm), Φb (%) | ||||
---|---|---|---|---|---|
Unbound | + Cu(II)c | Unbound | + Cu(II)c | + NOd | |
FL136 | 504, 4.2 ± 0.1 | 499, 4.0 ± 0.1 | 520, 7.7 ± 0.2 | 520, nr | 526, 58 ± 2 |
FL1E45 | 506, 2.08 ± 0.05 | 500, 0.77 ± 0.01 | 520, 2.57 ± 0.02 | 520, 3.37 ± 0.08 | 526, 22 ± 1 |
FL225 | 498, 2.91 ± 0.07 | 494, 1.14 ± 0.07 | 515, 0.74 ± 0.05 | 512, 0.76 ± 0.04 | 526, 51 ± 7 |
FL2E44 | 500, 1.79 ± 0.07 | 496, 1.12 ± 0.06 | 522, 0.37 ± 0.05 | 522, 0.72 ± 0.04 | 526, 40 ± 8 |
SFNL1 | 496, 0.85 ± 0.01 | 502, 0.468 ± 0.006 | 542, 2.7 ± 0.4 | 538, 2.1 ± 0.1 | 548,g 22 ± 1 |
517, 0.87 ± 0.01 | 527, 0.507 ± 0.006 | 544, 2.1 ± 0.1 | 543, 0.96 ± 0.04 | ||
SNFL1E | 496, 0.503 ± 0.004 | 504, 0.203 ± 0.002 | 541, 0.9 ± 0.1 | 538, 0.92 ± 0.09 | 549,g 24 ± 2 |
519, 0.520 ± 0.005 | 522, 0.408 ± 0.004 | 548, 0.72 ± 0.07 | 543, 0.59 ± 0.04 | ||
SNFL1Br | 505, 0.445 ± 0.005 | 504, 0.477 ± 0.007 | 544, 1.2 ± 0.2 | 542, 0.34 ± 0.02 | 548/597,h,i,j 14 ± 1 |
530, 0.465 ± 0.004 | 540, 0.54 ± 0.01 | 546, 0.9 ± 0.1 | 546, 0.14 ± 0.01 | ||
SNFL1EBr | 501, 0.407 ± 0.004 | 505, 0.47 ± 0.01 | f, 0.49 ± 0.06 | f, 0.34 ± 0.01 | 549/597,h,i,j 13 ± 1 |
532, 0.393 ± 0.003 | 536, 0.51 ± 0.01 | f, 0.25 ± 0.03 | f, 0.12 ± 0.01 |
Spectroscopic measurements were performed at in 50 mM PIPES and 100 mM KCl buffer at pH 7.0 at 25 °C.
Quantum yields are based on fluorescein (Φ = 0.95 in 0.1 N NaOH) or rhodamine-B (Φ = 0.54 in H2O).
One equiv of CuCl2 was added.
1300 equiv of NO, 60 min at 37 °C. Complexes generated in situ.
Broad emission, λmax ± 5 nm.
The broad emission prevented meaningful λmax determination.
λmax(UV) = λex = 517 nm,
λmax(UV) = λex = 527 nm.
The two emission maxima are of approximately equal intensity.
λex ≥ 530 nm results in an emission maxima at 615 nm.
Upon reaction with nitric oxide, the fluorescence of the Cu(II)-bound seminaphthofluorescein probes increased significantly. For all probes, the emission profile changes dramatically with the excitation wavelength (Figure 2, Figure S4). For example, excitation of SNFL1 and SNFL1E between 500 and 535 nm results in an emission maximum near 545 nm and a strong shoulder at 585 nm. Excitation at longer wavelengths between 535 and 550 nm, however, results in weak emission at 620 nm. The emission properties of SNFL1Br and SNFL1EBr are more complex than those of the non-brominated analogs. At shorter wavelength excitations, up to 525 nm, the emission maximum is at 550 nm with a weaker band near 600 nm. Above 530 nm excitation, the principal emission band at 550 nm decreases and the main emission shifts to 615 nm (Figure 2). Detailed 2D excitation/emission plots for all of the probes both before and after reaction with NO are supplied in the Supporting Information, Figure S4.
Figure 2.
Emission of (a) CuSNFL1 and (b) CuSNFL1Br before and after addition of NO as a function of excitation wavelength. The excitation peaks have been removed for clarity. (c) Integrated fluorescence turn-on as a function of excitation wavelength for CuSNFL1 and CuSNFL1Br. (d) Integrated emission of Cu2FL2 as a function of wavelength is shown for comparison. Conditions: 1 µM probe, 50 mM PIPES, 100 mM KCl, pH 7, 37 °C, 1300 equiv of NO incubated for 1 h.
By integrating the emission in both the on and off states of the probes as a function of excitation wavelength, the excitation-dependent magnitude of fluorescence turn-on was determined. For SNFL1, the fluorescence response to NO is maximal in the range between 525 and 535 nm with a net turn-on of 20-fold (42-fold for SNFL1E). SNFL1Br reaches a maximum turn-on of 22-fold (36-fold for SNFL1EBr) after reaction with NO near 535 nm to 575 nm. For comparison with the magnitude of turn-on using previously reported NO probes, a similar analysis was performed for FL2. A fluorescence turn-on of 23-fold had been observed using an excitation wavelength of 470 nm. Measurements of the fluorescence turn-on as a function of excitation revealed that, at λex = 515, nm there is a 92-fold increase in integrated emission.
Selectivity for NO over other RONS
Because a variety of reactive oxygen and nitrogen species (RONS) involved in biological processes are associated with nitric oxide, the NO selectivity of the seminaphthofluorescein probes was determined (Figure 3). Because of the excitation wavelength dependence of the turn on with NO, the response to RONS was monitored at various excitation wavelengths (Figure 3, top). For comparison between the probes, the λex = 530 nm was used (Figure 3, bottom). Addition of either NO or S-nitroso-N-acetyl-DL-penicillamine (SNAP), a common NO donor, resulted in a large, 20- to 45-fold increase in integrated emission. This observed turn on was identical to that observed after treatment with 1300 equiv of NO. Furthermore, all probes reached a maximum and constant fluorescent state within one hour of treatment with either SNAP or NO. By contrast, treatment with RONS such as NO3 −, NO2 −, ONOO−, HNO, H2O2, or OCl− did not result in fluorescence enhancement. Nitrogen dioxide (NO2), an oxidation product of NO that can directly nitrosate secondary amines, afforded minimal fluorescence turn-on. These results demonstrate the high selectivity of the seminaphthofluorescein probes for NO over other potential RONS in biological systems.
Figure 3.
Top: Selectivity of CuSNFL1 fluorescence response for NO over other reactive nitrogen and oxygen species as a function of excitation wavelength. Bottom: Comparison of the selectivity for NO over other RONS for CuSNFL1, CuSNFL1Br, CuSNFL1E, and CuSNFL1EBr. Conditions: 50 mM PIPES, 100 mM KCl, pH 7.0, 37 °C, 60 min, 100 equiv. of RONS, 1300 equiv. of NO, λex = 530 nm. The selectivity of the probes over a broad range of excitation wavelengths is reported in the Supporting Information (Figures S5–S8, Tables S2–S5).
pH Dependence
Much like the fluorescein-based FL1 and FL2 scaffolds, the emission of the seminaphthofluorescein scaffolds is pH-dependent. To examine the nature of this dependence, pH titrations were performed for SNFL1 and SNFL1Br using both UV-vis and fluorescence spectroscopy. The pH titrations were performed for the metal-free forms of the ligands to remove the Cu-binding equilibrium from the measurement. For both probes, the emission was highest in the 6–8 pH range, a region compatible for most biological experiments (Figure 4, left). For SNFL1, the UV-vis spectrum revealed a pKa of 7.3 (Figure 4, right). Similarly, measuring the integrated fluorescence as a function of pH revealed pKa values of 4.9, 6.3, and 7.5 (Figure S9). For the SNFL1Br probe, the UV-vis pH titration yielded a pKa of 7.5, and values of 5.5, 6.8, and 7.5 were determined by fluorescence spectroscopy (Figure S10). Although the fluorescence of SNFL1 and SNFL1Br change in the physiological pH range 6–8, the magnitude of the change in emission, ~2-fold, is an order of magnitude less than the fluorescence response of the probe to NO.
Figure 4.
Left: Integrated fluorescence as a function of pH for SNFL1 and SNFL1Br. Right: Change in absorbance in the UV-vis spectrum at 505 nm for SNFL1 and SNFL1Br as a function of pH. Conditions: 20 µM dye, 100 mM KCl, 25 °C.
Influence of Zn(II) on Fluorescence
Because of the similarity of the seminaphthofluorescein scaffolds to previous Zn(II) sensors developed in our laboratory,53,54 and because NO mediates Zn(II) release from metallothioneins,55–57 we investigated the potential of Zn(II) to elicit a fluorescence response from the seminaphthofluorescein-based NO probes. In particular, we titrated CuSNFL1 and CuSNFL1Br with Zn(II) and monitored the integrated emission as a function of added Zn(II) (Figure 5). Addition of 1, 5, 10, 50, 100, 500 or 1000 equiv of Zn(II) to a 10 µM solution of the Cu(II)-bound seminaphthofluorescein probes resulted in only negligible fluorescence. Even at 10 mM Zn(II), only a 5.5- and 2.5-fold turn-on, for CuSNFL1 and CuSNFL1Br, respectively, was observed. These results reveal that the seminaphthofluorescein probes are more sensitive to NO than to biological concentrations of Zn(II).
Figure 5.
Fluorescence response of CuSNFL1 and CuSNFL1Br to Zn(II). The fluorescence response for NO is shown for comparison. Conditions: 10 µM CuCl2, 10 µM probe, 50 mM PIPES, 100 mM KCl, pH 7.0, 25 °C. The Zn(II) concentration was adjusted with 10 mM or 1.0 mM ZnCl2.
Fluorescence imaging of endogenous NO
Having demonstrated the efficacy of the seminaphthofluorescein-based probes for NO detection in the cuvette, we next evaluated their biological compatibility by imaging NO produced in live cells. For these studies we investigated Raw 264.7 murine macrophage cells, which generate NO from iNOS upon stimulation with endotoxins and cytokines.58 Upon addition of lipopolysaccharide (LPS) and interferon-γ (INF-γ), Raw 264.7 cells produce micromolar concentrations of NO and are therefore ideal for evaluating the potential of the seminaphthofluorescein-based probes under biological conditions. Treatment of the cells with only the Cu(II)-bound fluorescent probes resulted in minimal observed emission. By contrast, stimulation with LPS and INF-γin the presence of the seminaphthofluorescein probes resulted in a significant increase in fluorescence intensity. In all cases, a significant emission enhancement occurred, thus demonstrating the suitability of the probes for detection of endogenous levels of NO. Representative images of the fluorescence both with and without stimulation of iNOS are presented in Figure 6. Sample line scans showing the magnitude of signal in both sets of cells are also included. Despite the ester functionality on the SNFL1E and SNFL1EBr probes, which is often used to impart cell trappability effected by hydrolysis by intracellular esterases to yield negatively charged carboxylates, the esterified seminaphthofluorescein probes diffused out of the cells in a manner similarly to that of the parent SNFL1 and SNFL1Br probes (See Supporting Information, Figures S11–S14).
Figure 6.
Fluorescence imaging of endogenous NO produced in Raw 264.7 cells. For each set of images, the left image corresponds to treatment with the fluorescent probe only. Images in the right panel correspond to cells treated with the fluorescent probes and stimulated with LPS and INF-γ. Top: DIC images; bottom: fluorescence images. The fluorescence intensity of the uncorrected fluorescence images are shown below to compare the fluorescence response in unstimulated and stimulated cells. [Probe] = 2 µM for CuSNFL1 and CuSFNL1Br, 4 µM for CuSNFL1E and CuSNFL1EBr. [LPS] = (0.75 ng/mL), [INF-γ] = (495 – 4950 U/mL), incubation for 14–16 h. Scale bars = 23 µm.
Summary
The synthesis and photophysical properties of seminaphthofluorescein-based fluorescent probes for nitric oxide are reported. Upon reaction with NO, the Cu(II) ligated SNFL1, SNFL1E, SNFL1Br, and SNFL1EBr probes exhibit 20- to 45-fold increases in integrated fluorescence. All of the probes are highly selective for NO or NO-donors over other reactive oxygen and nitrogen species. Treatment of the Cu(II)-bound ligands with a large excess of Zn(II) did not elicit a significant fluorescence response. All of the seminaphthofluorescein probes are cell permeable and can be used to image endogenous levels of NO, as demonstrated in Raw 264.7 murine macrophage cells.
Experimental Section
Synthetic Materials and Methods
Seminaphthofluorescein precursors 1, 3, and 5,53 aminoquinaldines 759 and 8,60 and FL225 and FL2E44 were prepared as described previously. Silica gel (SiliaFlash F60, Silicycle, 230–400 mesh) was used for column chromatography. Thin-layer chromatography (TLC) was performed on J. T. Baker 1B–F silica gel plates (250 µM thickness) and viewed by UV illumination. Preparative TLC was performed on Silicycle SiliaPlates (1000 µM thickness). NMR spectra were acquired on a Bruker 400 MHz spectrometer at ambient temperature. Chemical shifts are reported in parts per million (δ) and are referenced to residual protic solvent resonances. The following abbreviations are used in describing NMR couplings: (s) singlet, (d) doublet, (t) triplet, (q) quartet, (b) broad, (m) multiplet. Melting points were measured on a MelTemp apparatus and are reported as uncorrected temperatures. High-resolution mass spectra were measured by the staff at the MIT Department of Chemistry Instrumentation Facility (DCIF). Elemental analyses were performed by Midwest MicroLabs.
Spectroscopic Materials and Methods
Piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES, Calbiochem) and potassium chloride (99.999%, Aldrich) were used to make buffered solutions (50 mM PIPES, 100 mM KCl, pH 7.0) with Millipore water. Nitric oxide was purchased from Airgas and was purified as described previously.61 Nitrogen dioxide (NO2) was purchased from Aldrich and purified by condensation into a gas bulb at −78 °C followed by exposure to vacuum to remove higher-boiling impurities. S-nitroso-N-acetyl-DL-penicillamine (SNAP), sodium peroxynitrite, sodium nitrite, and Angeli’s salt (Na2N2O3) were purchased from Cayman Chemical and stored at −80 °C prior to use. Nitric oxide and NO2, as well as 1.0 mM solution of other reactive oxygen and nitrogen species (RONS), were introduced into buffered solutions via gas tight syringes. Copper(II) chloride dihydrate (99+%, Alfa Aesar) was used to prepare 1.0 mM CuCl2 stock solutions with Millipore water. Stock solutions of the fluorescent probes were prepared in DMSO and stored in aliquots at −80 °C until immediately prior to use. UV-visible spectra were acquired on a Cary 50-Bio or a Cary 1E spectrometer. Acquisitions were made at 25.00 ± 0.05 °C. Fluorescence spectra were obtained on a Quanta Master 4 L-format scanning spectrofluorimeter (Photon Technology International) at 25.0 ± 0.1 °C or 37.0 ± 0.1 °C. All fluorescence measurements were made under anaerobic conditions, with cuvette solutions prepared in an inert atmosphere glove box. All UV-vis and fluorescence experiments were repeated at least in triplicate.
Cell Culture and Imaging Materials and Methods
Raw 264.7 murine macrophages were obtained from ATCC and were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Cellgro, MediaTek, Inc.) supplemented with 10% fetal bovine serum (FBS, HyClone), 1% penicillin-streptomycin, 1% sodium pyruvate (Cellgro, MediaTek, Inc.), and 1% MEM non-essential amino acids (Sigma). For imaging studies, cells grown to confluence were passed and plated into poly-D-lysine coated plates (MatTek) containing 2 mL of DMEM. After incubation at 37 °C with 5% CO2 for at least five hours, the media was removed, the cells were washed with 2 mL of PBS buffer, and 2 mL of fresh DMEM was added along with the fluorescent probes and/or iNOS stimulants. Cells were incubated for 14–16 h prior to imaging. For all cell studies, the Cu(II) complexes of the fluorescent probes were generated in situ by combining stock solutions of CuCl2 and the dye. For all comparison studies, the plates were loaded with identical amounts of the cell stock solution to ensure an equal number of cells were passed to each plate.
For nitric oxide detection studies, NO production by iNOS was induced in Raw 264.7 macrophages with 0.75 ng/mL of lipopolysaccharide (LPS, Sigma) and 495–4950 U/mL of interferon-gamma (IFN-γ, BD Biosciences). The concentrations of LPS and INF-γ were optimized using Cu2FL2E. Cells were then co-incubated with either 2 µM CuSNFL1, 2 µM CuSNFL1Br, 4 µM CuSNFL1E, or 4 µM CuSNFL1EBr and 4.5 µM Hoechst 33258 (Sigma). Prior to imaging, cells were washed with 2 mL of PBS and then bathed in 2 mL of warm PBS during imaging.
Fluorescence Microscopy
Images were acquired on a Zeiss Axiovert 200M inverted epifluorescence microscope equipped with an EM-CCD digital camera (Hamamatsu) and an X-Cite 120 metal-halide lamp (EXFO). Differential interference contrast (DIC) and fluorescence images were obtained using an oil immersion 63× objective lens, with exposure time ranging from 250 ms to 1.75 s. Emission from the seminaphthofluorescein-based probes was detected using a custom filter set (Chroma) with a 500 nm excitation filter (HQ500/40×), a 530 nm dichroic mirror (Q530LP), and a 550 nm long pass emission filter (E550LP). The microscope was operated with Volocity software (Improvision) and images were analyzed with either the Volocity software or ImageJ.62 All fluorescent images were corrected for background. Uncorrected images are shown in the Supporting Information (Figures S15–S18).
X-ray Data Collection and Structure Solution Refinement
Crystals of 6 of suitable quality for X-ray diffraction were grown by diffusion of hexanes into a CHCl3 solution of 6. A single crystal was mounted in Paratone N oil using 30 µm aperture MiTeGen MicroMounts (Ithaca, NY) loop and frozen under a nitrogen cold stream maintained by a KRYO-FLEX low-temperature apparatus set to 100 K. Data were collected on a Bruker SMART APEX CCD X-ray diffractometer with Mo(Kα) radiation (λ = 0.71073 Å) controlled by the APEX2 software package (v. 2010.).63 Data reduction was performed with SAINT and empirical absorption corrections were applied with SADABS.64 The structures were solved by direct methods with refinement by full-matrix least squares based on F2 using SHELXTL-97.65,66 All non-hydrogen atoms were located and their positions refined anisotropically. Hydrogen atoms were assigned to idealized positions and given thermal parameters equal to 1.2 times the thermal parameters of the atoms to which they were attached.
Syntheses
8-Bromo-11-(bromomethyl)-3'-oxo-3'H-spiro[benzo-[c]xanthene-7,1'-isobenzofuran]-3,10-diyl dibenzoate, 4
A mixture of dibenzoate 1 (11.9 g, 19.7 mmol), 1,3-dibromo-5,5-dimethyl hydantoin (2 (12.7 g, 44.4 mmol), VAZO 88 (660 mg, 2.71 mmol), and glacial acetic acid (420 µL, 7.3 mmol) was added to 300 mL of chlorobenzene and heated at 60 °C for seven days. The resultant solution was washed with hot water, dried with MgSO4, and the solvents were removed under vacuum. The resultant solid was recrystallized from a minimal amount of toluene and ethanol (~10:1) to yield the desired product (13.4 g, 89% yield). Note: If the bromination does not go to completion, excess VAZO 88 or 2 can be added during the course of the reaction. 1H NMR (400 MHz, CDCl3): δ 8.72 (d, J = 8.8, 1H, ArH), 8.24 (d, J = 7.2, 4H, ArH), 8.06 (m, 2H, ArH), 7.67 (m, 5H, ArH), 7.52 (m, 4H, ArH), 7.20 (d, J = 8.0, 1H, ArH), 7.11 (s, 1H, ArH), 7.06 (d, J = 8.8, 1H, ArH), 6.91 (d, J = 8.4, 1H, ArH) 4.88 (m, 2H, CH2). 13C{1H} NMR (100 MHz, CDCl3): δ 169.2, 165.2, 164.4, 152.9, 152.0, 149.4, 146.3, 135.5, 134.5, 134.2, 130.7, 130.6, 130.5, 129.24, 129.17, 129.10, 128.92, 128.7, 128.1, 126.1, 125.7, 124.7, 124.4, 123.7, 123.1, 119.35, 119.30, 119.22, 117.16, 117.05, 113.51, 81.7, 20.5. HRMS ([M + H]+). Calcd m/z: 760.9805. Found m/z: 760.9827. Anal. Calcd for C39H22Br2O7EtOH: C, 60.91; H, 3.49; Found: C, 60.81; H, 3.21. Mp 171–173 °C (decomp).
2-(11-Formyl-10-hydroxy-8-bromo-3-oxo-3H-benzo[c]xanthen-7-yl)benzoic acid, 6
The seminaphthofluorescein bromide 4 (2.0 g, 2.9 mmol) was combined with NaHCO3 (2.0 g, 24 mmol) in 70 mL of DMSO and heated to 140 °C for 3 h. The reaction mixture was cooled to room temperature, poured into 350 mL of 4 M HCl, and stirred for 30 min. The solution was filtered, washed with water, and dried under vacuum. The resultant crude product was purified using two SiO2 columns. The first column was eluted with 10% MeOH in CH2Cl2. The second column was eluted with 2% MeOH in CH2Cl2 to yield the pure aldehyde 6 (59 mg, 5% yield). 1 NMR (400 MHz, 10:1 CD2Cl2:d4-MeOD): δ 8.35 (d, J = 9.2, 1H, ArH), 8.06 (d, J = 7.6, 1H, ArH), 7.72 (m, 2H, ArH), 7.45 (s, 1H, ArH), 7.29 (d, J = 9.2, 1H, ArH), 7.17 (d, J = 7.6, 1H, ArH), 6.96 (s, 1H, ArH), 6.93 (d, J = 9.2, 1H, ArH), 6.66 (d, J = 9.2, 1H, ArH). 13C{1H} NMR (100 MHz, 10:1 CD2Cl2:d4-MeOD): δ 193.5, 170.2, 164.8, 159.3, 153.1, 153.0, 146.5, 137.5, 136.5, 135.5, 131.1, 127.8, 126.9, 125.9, 124.8, 124.6, 120.4, 119.3, 116.8, 114.8, 111.3, 111.3, 111.1, 109.8, 82.8. HRMS ([M + H]+). Calcd m/z: 488.9968. Found m/z: 488.9954. Anal. Calcd for C25H13BrO6MeOH: C, 50.90; H, 3.29; Found: C, 60.13; H, 3.66. Mp > 300 °C.
2-(10-Hydroxy-11-(((2-methylquinolin-8-yl)amino)methyl)-3-oxo-3H-benzo[c]xanthen-7-yl)benzoic acid, SNFL1
The seminaphthofluorescein aldehyde 5 (13.4 mg, 32.7 µmol) and 2-methylquinolin-8-amine (7) (6.2 mg, 49 µmol) were combined in 2 mL of anhydrous MeOH and 2 mL of anhydrous CH2Cl2 containing 4 Å molecular sieves. The solution was protected from light and stirred for 1 h, after which the reaction solution was cooled to 0 °C. Next, NaBH(OAc)3 (34 mg, 163 µmol) was added in one portion. The solution was allowed to warm to room temperature and stirred overnight. After filtration and removal of the solvents under vacuum, the residual red solid was dissolved in a minimal amount of MeOH and purified by preparative TLC eluting with 5% MeOH in CH2Cl2 to afford SNFL1 (5.9 mg, 30% yield). 1 NMR (400 MHz, 10:1 CD2Cl2:d4-MeOH): δ 8.38 (d, J = 9.2, 1H, ArH), 8.02 (d, J = 6.8 Hz, 1H, ArH), 7.96 (d, J = 8.4, 1H, ArH), 7.62 (m, 2H, ArH), 7.28 (overlapping m, 3H, ArH), 7.13 (overlapping m, 5H, ArH), 6.69 (d, J = 8.4, 2H, ArH), 6.62 (d, J = 7.2, 1H, ArH), 5.02 (s, 2H, CH2), 2.54 (s, 3H, CH3). HRMS ([M - H]−). Calcd m/z: 551.1612. Found m/z: 551.1608. Mp 185–187 (decomp).
2-(11-(((6-(2-Ethoxy-2-oxoethoxy)-2-methylquinolin-8-yl)amino)methyl)-10-hydroxy-3-oxo-3H-benzo[c]xanthen-7-yl)benzoic acid, SNFL1E
The seminaphthofluorescein aldehyde 5 (27.0 mg, 65.7 µmol) and aminoquinaldine ester 8 (22.2 mg, 85.7 µmol) were combined in 2 mL of anhydrous MeOH and 2 mL of anhydrous CH2Cl2 containing 4 Å molecular sieves. The solution was protected from light and stirred for 2 h, after which the reaction solution was cooled to 0 °C. After cooling, NaBH(OAc)3 (25.1 mg, 118 µmol) was added in one portion. The solution was allowed to warm to room temperature and stirred for 3 h. After filtration and removal of the solvents under vacuum, the red residual solid was dissolved in a minimal amount of MeOH and purified by preparative TLC eluting with 8% MeOH in CH2Cl2 to yield SNFL1E (8.9 mg, 16% yield) 1 NMR (400 MHz, 10:1 CD2Cl2:d4-MeOH): δ 8.45 (d, J = 8.8 Hz, 1H, ArH), 8.03 (bs, 1H, ArH), 7.81 (d, J = 8.0 Hz, 1H, ArH), 7.61 (bs, 2H, ArH), 7.27 (d, J = 8.8 Hz, 1H, ArH), 7.17 (m, 3H, ArH), 7.13 (s, 1H, ArH), 6.80 (overlapping m, 3H, ArH), 6.28 (d, J = 8.8 Hz, 1H, ArH), 6.29 (s, 1H, ArH), 4.90 (s, 2H, CH2), 4.66 (s, 2H, CH2), 4.22 (q, J = 7.2 Hz, 2H, CH2), 2.44 (s, 3H, CH3), 1.26 (t, J = 4.8 Hz, 3H, CH3). HRMS ([M - H]−). Calcd m/z: 653.1929. Found m/z: 653.1936. Mp 174–177 °C (decomp).
2-(8-Bromo-10-hydroxy-11-(((2-methylquinolin-8-yl)amino) methyl)-3-oxo-3H-benzo[c]xanthen-7-yl)benzoic acid, SNFL1Br
The brominated seminaphthofluorescein aldehyde 6 (16.1 mg, 39.2 µmol) and 2-methylquinolin-8-amine (7) (6.8 mg, 43 µmol) were combined in 2 mL of anhydrous MeOH and 3 mL of anhydrous CH2Cl2 containing 4 Å molecular sieves. The solution was protected from light and stirred for 3 h, after which the reaction solution was cooled to 0 °C. After cooling, NaBH(OAc)3 (16 mg, 78 µmol) was added in one portion. The solution was allowed to warm to room temperature and stirred overnight. After filtration and removal of the solvents under vacuum, the red residual solid was dissolved in a minimal amount of MeOH and purified by preparative TLC eluting with 10% MeOH in CH2Cl2 to yield SNFL1Br (9.3 mg, 41% yield). 1 NMR (400 MHz, 10:1 CD2Cl2:d4-MeOH): δ 8.43 (d, J = 8.4, 1H, ArH), 8.06 (bs, 1H, ArH), 7.95 (d, J = 8.4, 1H, ArH), 7.66 (bs, 2H, ArH), 7.45 (s, 1H, ArH), 7.32 (t, J = 6.4, 1H, ArH), 7.18 (overlapping m, 4H, ArH), 7.09 (d, J = 8.4, 1H, ArH), 7.06 (s, 1H, ArH), 6.73 (d, J = 8.4, 1H, ArH), 6.64 (d, J = 8.4, 1H, ArH), 4.96 (s, 2H, CH2), 2.50 (s, 3H, CH3). HRMS ([M + H]+). Calcd m/z: 631.0863. Found m/z: 631.0841. Mp 179–181 °C (decomp).
2-(8-Bromo-11-(((6-(2-ethoxy-2-oxoethoxy)-2-methylquinolin-8-yl)amino)methyl)-10-hydroxy-3-oxo-3H-benzo[c]xanthen-7-yl)benzoic acid, SFNL1EBr
The brominated seminaphthofluorescein aldehyde 6 (13.1 mg, 31.8 µmol) and aminoquinaldine ester 8 (10.4 mg, 39.4 µmol) were combined in 1 mL of anhydrous MeOH and 1 mL of anhydrous CH2Cl2 containing 4 Å molecular sieves. The solution was protected from light and stirred for 2 h, after which the reaction solution was cooled to 0 °C. After cooling, NaBH(OAc)3 (13.5 mg, 63.6 µmol) was added in one portion. The reaction mixture was allowed to warm to room temperature and stirred for 2 h, after which it was filtered and the solvents were removed under vacuum. The red residual solid was dissolved in a minimal amount of MeOH and purified by preparative TLC eluting with 6% MeOH in CH2Cl2 to yield SNFL1EBr (12 mg, 58% yield). 1H NMR (400 MHz, d4-MeOH): δ 8.46 (d, J = 8.8, 1H, ArH), 8.05 (dd, J = 6.4, 2.4, 1H, ArH), 7.80 (d, J = 8.4, 1H, ArH), 7.70 (m, 2H, ArH), 7.44 (d, J = 2.0, 1H, ArH), 7.19 (overlapping m, 2H, ArH), 7.12 (d, J = 8.4, 1H, ArH), 6.49 (s, 1H, ArH), 6.87 (d, J = 1.6, 1H, ArH), 6.69 (s, 2H, ArH), 6.35 (d, J = 2.4, 1H, ArH), 4.68 (s, 2H, CH2), 4.62 (bs, 2H, CH2), 4.22 (q, J = 6.8 Hz, 2H, CH2), 2.36 (s, 3H, CH3), 1.25 (t, J = 6.8, 3H, CH3). HRMS ([M + H]+). Calcd m/z: 733.1180. Found m/z: 733.1177. Mp: 169–171 °C (decomp).
Supplementary Material
Acknowledgment
This work was supported the National Science Foundation (CHE-0611944 to SJL) and the National Institutes of Health (K99GM092970 to MDP). Instrumentation in the MIT DCIF is maintained with funding from NIH grant 1S10RR13886-01. The authors thank Daniela Buccella for helpful discussions and suggestions.
Footnotes
Supporting Information Available X-ray crystallographic data of compound 6 in CIF format, excitation/emission plots for all probes, selectivity plots and data for various excitation wavelengths, pH profiles, raw cell images, cell washing studies, NMR spectra. This information is available free of charge via the Internet at http://pubs.acs.org
References
- 1.Rapoport RM, Draznin MB, Murad F. Nature. 1983;306:174–176. doi: 10.1038/306174a0. [DOI] [PubMed] [Google Scholar]
- 2.Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Proc. Natl. Acad. Sci. U. S. A. 1987;84:9265–9269. doi: 10.1073/pnas.84.24.9265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Furchgott RF, Vanhoutte PM. FASEB J. 1989;3:2007–2018. [PubMed] [Google Scholar]
- 4.Ignarro LJ. Nitric Oxide Biology and Pathobiology. 1st ed. San Diego: Academic Press; 2000. [Google Scholar]
- 5.Garthwaite JE. J. Neurosci. 2008;27:2783–2802. doi: 10.1111/j.1460-9568.2008.06285.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pluth MD, Tomat E, Lippard SJ. Annu. Rev. Biochem. 2011;80 doi: 10.1146/annurev-biochem-061009-091643. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Brown GC, Bal-Price A. Mol. Neurobiol. 2003;27:325–355. doi: 10.1385/MN:27:3:325. [DOI] [PubMed] [Google Scholar]
- 8.Heales SJR, Bolaños JP, Stewart VC, Brookes PS, Land JM, Clark JB. Biochim. Biophys. Acta-Bioenerg. 1999;1410:215–228. doi: 10.1016/s0005-2728(98)00168-6. [DOI] [PubMed] [Google Scholar]
- 9.Johnson RA, Freeman RH. Am. J. Hypertens. 1992;5:919–922. doi: 10.1093/ajh/5.12.919. [DOI] [PubMed] [Google Scholar]
- 10.Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, Wada I, Akira S, Araki E, Mori M. Proc. Natl. Acad. Sci. U. S. A. 2001;98:10845–10850. doi: 10.1073/pnas.191207498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pieper GM. Hypertension. 1998;31:1047–1060. doi: 10.1161/01.hyp.31.5.1047. [DOI] [PubMed] [Google Scholar]
- 12.Smith KJ, Lassmann H. Lancet Neurol. 2002;1:232–241. doi: 10.1016/s1474-4422(02)00102-3. [DOI] [PubMed] [Google Scholar]
- 13.Titheradge MA. Biochim. Biophys. Acta-Bioenerg. 1999;1411:437–455. doi: 10.1016/s0005-2728(99)00031-6. [DOI] [PubMed] [Google Scholar]
- 14.Ye X, Rubakhin SS, Sweedler JV. Analyst. 2008;133:423–433. doi: 10.1039/b716174c. [DOI] [PubMed] [Google Scholar]
- 15.Ghafourifar P, Parihar MS, Nazarewicz R, Zenebe WJ, Parihar A. Nitric Oxide, Part F: Oxidative and Nitrosative Stress in Redox Regulation of Cell Signaling. 2008;Vol. 440:317–334. [Google Scholar]
- 16.Hetrick EM, Schoenfisch MH. Annu. Rev. Anal. Chem. 2009;2:409–433. doi: 10.1146/annurev-anchem-060908-155146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.McQuade LE, Lippard SJ. Curr. Opin. Chem. Biol. 2010;14:43–49. doi: 10.1016/j.cbpa.2009.10.004. [DOI] [PubMed] [Google Scholar]
- 18.Nagano T. J. Clin. Biochem. Nut. 2009;45:111–124. doi: 10.3164/jcbn.R09-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Nagano T, Yoshimura T. Chem. Rev. 2002;102:1235–1269. doi: 10.1021/cr010152s. [DOI] [PubMed] [Google Scholar]
- 20.Sasaki E, Kojima H, Nishimatsu H, Urano Y, Kikuchi K, Hirata Y, Nagano T. J. Am. Chem. Soc. 2005;127:3684–3685. doi: 10.1021/ja042967z. [DOI] [PubMed] [Google Scholar]
- 21.Kojima H, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Tanaka J, Kudo Y, Nagano T. Neuroreport. 1998;9:3345–3348. doi: 10.1097/00001756-199810260-00001. [DOI] [PubMed] [Google Scholar]
- 22.Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T. Anal. Chem. 1998;70:2446–2453. doi: 10.1021/ac9801723. [DOI] [PubMed] [Google Scholar]
- 23.Kojima H, Sakurai K, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Akaike T, Maeda H, Nagano T. Biol. Pharm. Bull. 1997;20:1229–1232. doi: 10.1248/bpb.20.1229. [DOI] [PubMed] [Google Scholar]
- 24.Sato M, Nakajima T, Goto M, Umezawa Y. Anal. Chem. 2006;78:8175–8182. doi: 10.1021/ac061791b. [DOI] [PubMed] [Google Scholar]
- 25.McQuade LE, Lippard SJ. Inorg. Chem. 2010;49:7464–7471. doi: 10.1021/ic100802q. [DOI] [PubMed] [Google Scholar]
- 26.Yang YJ, Seidlits SK, Adams MM, Lynch VM, Schmidt CE, Anslyn EV, Shear JB. J. Am. Chem. Soc. 132:13114–13116. doi: 10.1021/ja1040013. [DOI] [PubMed] [Google Scholar]
- 27.Zhang JQ, Boghossian AA, Barone PW, Rwei A, Kim JH, Lin DH, Heller DA, Hilmer AJ, Nair N, Reuel NF, Strano MS. J. Am. Chem. Soc. 2011;133:567–581. doi: 10.1021/ja1084942. [DOI] [PubMed] [Google Scholar]
- 28.Kim JH, Heller DA, Jin H, Barone PW, Song C, Zhang J, Trudel LJ, Wogan GN, Tannenbaum SR, Strano MS. Nat. Chem. 2009;1:473–481. doi: 10.1038/nchem.332. [DOI] [PubMed] [Google Scholar]
- 29.Barker SLR, Clark HA, Swallen SF, Kopelman R, Tsang AW, Swanson JA. Anal. Chem. 1999;71:1767–1772. doi: 10.1021/ac9810462. [DOI] [PubMed] [Google Scholar]
- 30.Barker SLR, Zhao YD, Marletta MA, Kopelman R. Anal. Chem. 1999;71:2071–2075. doi: 10.1021/ac9901081. [DOI] [PubMed] [Google Scholar]
- 31.Sato M, Hida N, Umezawa Y. Proc. Natl. Acad. Sci. U. S. A. 2005;102:14515–14520. doi: 10.1073/pnas.0505136102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Katayama Y, Takahashi S, Maeda M. Anal. Chim. Acta. 1998;365:159–167. [Google Scholar]
- 33.Kojima H, Hirotani M, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Hirata Y, Nagano T. Anal. Chem. 2001;73:1967–1973. doi: 10.1021/ac001136i. [DOI] [PubMed] [Google Scholar]
- 34.Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, Beger HG, Morris SM, Bruckner UB. Nitric Oxide Biol. Chem. 1997;1:177–189. doi: 10.1006/niox.1997.0116. [DOI] [PubMed] [Google Scholar]
- 35.Nagano T, Takizawa H, Hirobe M. Tetrahedron Lett. 1995;36:8239–8242. [Google Scholar]
- 36.Lim MH, Xu D, Lippard SJ. Nat. Chem. Biol. 2006;2:375–380. doi: 10.1038/nchembio794. [DOI] [PubMed] [Google Scholar]
- 37.Ouyang J, Hong H, Shen C, Zhao Y, Ouyang CG, Dong L, Zhu JH, Guo ZJ, Zeng K, Chen JN, Zhang CY, Zhang JF. Free Radical Biol. Med. 2008;45:1426–1436. doi: 10.1016/j.freeradbiomed.2008.08.016. [DOI] [PubMed] [Google Scholar]
- 38.Hilderbrand SA, Lim MH, Lippard SJ. J. Am. Chem. Soc. 2004;126:4972–4978. doi: 10.1021/ja038471j. [DOI] [PubMed] [Google Scholar]
- 39.Lim MH, Lippard SJ. Inorg. Chem. 2004;43:6366–6370. doi: 10.1021/ic035418n. [DOI] [PubMed] [Google Scholar]
- 40.Ortiz M, Torrens M, Mola JL, Ortiz PJ, Fragoso A, Diaz A, Cao R, Prados P, de Mendoza J, Otero A, Antinolo A, Lara A. Dalton Trans. 2008:3559–3566. doi: 10.1039/b718645b. [DOI] [PubMed] [Google Scholar]
- 41.Soh N, Katayama Y, Maeda M. Analyst. 2001;126:564–566. doi: 10.1039/b101600h. [DOI] [PubMed] [Google Scholar]
- 42.Lim MH, Lippard SJ. Acc. Chem. Res. 2007;40:41–51. doi: 10.1021/ar950149t. [DOI] [PubMed] [Google Scholar]
- 43.Lim MH, Wong BA, Pitcock WH, Mokshagundam D, Baik MH, Lippard SJ. J. Am. Chem. Soc. 2006;128:14364–14373. doi: 10.1021/ja064955e. [DOI] [PubMed] [Google Scholar]
- 44.McQuade LE, Ma J, Lowe G, Ghatpande A, Gelperin A, Lippard SJ. Proc. Natl. Acad. Sci. U. S. A. 2010;107:8525–8530. doi: 10.1073/pnas.0914794107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Pluth MD, McQuade LE, Lippard SJ. Org. Lett. 2010;12:2318–2321. doi: 10.1021/ol1006289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.McQuade LE, Pluth MD, Lippard SJ. Inorg. Chem. 2010;49:8025–8033. doi: 10.1021/ic101054u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhou Y, Marcus EM, Haugland RP, Opas MJ. Cell. Physiol. 1995;164:9–16. doi: 10.1002/jcp.1041640103. [DOI] [PubMed] [Google Scholar]
- 48.Kuwana E, Sevick-Muraca EM. Anal. Chem. 2003;75:4325–4329. doi: 10.1021/ac034059a. [DOI] [PubMed] [Google Scholar]
- 49.Aslan K, Lakowicz JR, Szmacinski H, Geddes CD. J. Fluoresc. 2005;15:37–40. doi: 10.1007/s10895-005-0211-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Nolan EM, Lippard SJ. J. Mater. Chem. 2005;15:2778–2783. [Google Scholar]
- 51.Nolan EM, Lippard SJ. J. Am. Chem. Soc. 2007;129:5910–5918. doi: 10.1021/ja068879r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Salerno M, Ajimo JJ, Dudley JA, Binzel K, Urayama P. Anal. Biochem. 2007;362:258–267. doi: 10.1016/j.ab.2006.12.042. [DOI] [PubMed] [Google Scholar]
- 53.Chang CJ, Jaworski J, Nolan EM, Sheng M, Lippard SJ. Proc. Natl. Acad. Sci. U. S. A. 2004;101:1129–1134. doi: 10.1073/pnas.0308079100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Nolan EM, Jaworski J, Okamoto KI, Hayashi Y, Sheng M, Lippard SJ. J. Am. Chem. Soc. 2005;127:16812–16823. doi: 10.1021/ja052184t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Aravindakumar CT, Ceulemans J, De Ley M. Biochem. J. 1999;344:253–258. doi: 10.1042/0264-6021:3440253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Berendji D, KolbBachofen V, Meyer KL, Grapenthin O, Weber H, Wahn V, Kroncke KD. FEBS Lett. 1997;405:37–41. doi: 10.1016/s0014-5793(97)00150-6. [DOI] [PubMed] [Google Scholar]
- 57.Kroncke KD, Fehsel K, Schmidt T, Zenke FT, Dasting I, Wesener JR, Bettermann H, Breunig KD, Kolbbachofen V. Biochem. Biophys. Res. Commun. 1994;200:1105–1110. doi: 10.1006/bbrc.1994.1564. [DOI] [PubMed] [Google Scholar]
- 58.Bogdan C. Nat. Immunol. 2001;2:907–916. doi: 10.1038/ni1001-907. [DOI] [PubMed] [Google Scholar]
- 59.Xue GP, Bradshaw JS, Dalley NK, Savage PB, Krakowiak KE, Izatt RM, Prodi L, Montalti M, Zaccheroni N. Tetrahedron. 2001;57:7623–7628. [Google Scholar]
- 60.Fahrni CJ, O'Halloran TV. J. Am. Chem. Soc. 1999;121:11448–11458. [Google Scholar]
- 61.Lim MD, Lorkovic IM, Ford PC. Nitric Oxide, Pt E. 2005;Vol. 396:3–17. doi: 10.1016/S0076-6879(05)96001-1. [DOI] [PubMed] [Google Scholar]
- 62.Rasband WS. ImageJ. Bethesda, Maryland, USA: U. S. National Institutes of Health; pp. 1997–2011. [Google Scholar]
- 63.APEX2, 2008-4.0. Madison, WI: Bruker AXS, Inc; 2008. [Google Scholar]
- 64.Sheldrick GM. SADABS: Area-Detector Absorption Correction. Germany: University of Gttingen: Gttingen; 2008. [Google Scholar]
- 65.Sheldrick GM. SHELXTL-97, 6.14. Germany: University of Gttingen: Gttingen; 2000. [Google Scholar]
- 66.Sheldrick GM. Acta Crystallogr., Sect. A. 2008;64:112–122. doi: 10.1107/S0108767307043930. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.